Comparative effects of acute-methionine loading on the plasma sulfur-amino acids in NAC-supplemented HIV+ patients and healthy controls.
Study Goal
The researchers aimed to investigate the effects of N-acetyl-L-cysteine (NAC) supplementation on the transsulfuration pathway and antioxidant capacity in HIV+ patients compared to healthy controls.
Results Summary
NAC supplementation increased remethylation and normalized transsulfuration in HIV+ patients, boosting plasma glutathione (GSH) levels above controls but failing to restore normal cysteine (Cys) levels due to higher consumption in GSH and taurine synthesis pathways.
Population
20 non-HIV+ control subjects and 12 HIV+ HAART-treated patients.
Effective Dosage
1 g/day of NAC.
Duration
7 days per dietary situation (NAC supplementation vs. usual diet).
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
usual diet | decrease | plasma GSH | HIV+ HAART-treated patients | - | had lower | #1 |
usual diet | decrease | plasma amino acids (excepting Hcy) | HIV+ HAART-treated patients | - | had lower | #2 |
usual diet | increase | oxidative stress (GSSG/GSH ratio) | HIV+ HAART-treated patients | - | had higher | #3 |
usual diet | no change | remethylation (RM: Me/Hcy + Ser ratio) | HIV+ HAART-treated patients | - | had similar | #4 |
usual diet | no change | transmethylation (TM; Hcy/Met ratio) | HIV+ HAART-treated patients | - | had similar | #5 |
usual diet | no change | glutaminogenesis (Glu/Gln ratio) | HIV+ HAART-treated patients | - | had similar | #6 |
usual diet | decrease | transsulfuration (TS: Cys/Hcy + Ser ratio) | HIV+ HAART-treated patients | - | had lower | #7 |
usual diet | decrease | Cys/Met ratio | HIV+ HAART-treated patients | - | had lower | #8 |
usual diet | increase | synthetic rates of glutathione (GG: GSH/Cys ratio) | HIV+ HAART-treated patients | - | had higher | #9 |
usual diet | increase | synthetic rates of Tau (TG: Tau/Cys ratio) | HIV+ HAART-treated patients | - | had higher | #10 |
dietary N-acetyl-L-cysteine (NAC) supplementation | increase | remethylation (RM) | HIV+ HAART-treated patients | above control | changed the HIV pattern by increasing | #11 |
dietary N-acetyl-L-cysteine (NAC) supplementation | no change | plasma Met | HIV+ HAART-treated patients | - | normalizing | #12 |
dietary N-acetyl-L-cysteine (NAC) supplementation | no change | transsulfuration (TS) | HIV+ HAART-treated patients | - | normalizing | #13 |
dietary N-acetyl-L-cysteine (NAC) supplementation | increase | plasma GSH | HIV+ HAART-treated patients | above controls | increasing | #14 |
dietary N-acetyl-L-cysteine (NAC) supplementation | increase | synthetic rates of glutathione (GG) | HIV+ HAART-treated patients | above controls | increasing | #15 |
dietary N-acetyl-L-cysteine (NAC) supplementation | decrease | plasma Cys | HIV+ HAART-treated patients | below controls | kept | #16 |
acute overloading of methionine (MetLo) | no change | plasma Cys | HIV+ HAART-treated patients | - | failure of restoring normal Cys | #17 |
In this study, an acute overloading of methionine (MetLo) was used to investigate the trassulfuration pathway response comparing healthy controls and HIV+ patients under their usual diet and dietary N-acetyl-L-cysteine (NAC) supplementation. MetLo (0.1 g Met/kg mass weight) was given after overnight fasting to 20 non-HIV+ control subjects (Co) and 12 HIV+ HAART-treated patients. Blood samples were taken before and after the MetLo in two different 7-day dietary situations, with NAC (1 g/day) or with their usual diet (UD). The amino acids (Met, Hcy, Cys, Tau, Ser, Glu and Gln) and GSH were determined by HPLC and their inflow rate into circulation (plasma) was estimated by the area under the curve (AUC). Under UD, the HIV+ had lower plasma GSH and amino acids (excepting Hcy) and higher oxidative stress (GSSG/GSH ratio), similar remethylation (RM: Me/Hcy + Ser ratio), transmethylation (TM; Hcy/Met ratio) and glutaminogenesis (Glu/Gln ratio), lower transsulfuration (TS: Cys/Hcy + Ser ratio) and Cys/Met ratio and, higher synthetic rates of glutathione (GG: GSH/Cys ratio) and Tau (TG: Tau/Cys ratio). NAC supplementation changed the HIV pattern by increasing RM above control, normalizing plasma Met and TS and, increasing plasma GSH and GG above controls. However, plasma Cys was kept always below controls probably, associatively to its higher consumption in GG (more GSSG than GSH) and TG. The failure of restoring normal Cys by MetLo, in addition to NAC, in HIV+ patients seems to be related to increased flux of Cys into GSH and Tau pathways, probably strengthening the cell-antioxidant capacity against the HIV progression (registered at http://www.clinicaltrials.gov , NCT00910442).